Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902664-25-003581·Avoro Capital Advisors LLC
Schedule 13G ownership disclosure
Monte Rosa Therapeutics Inc
Common Stock, par value $0.0001 per share · CUSIP: 61225M102
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Avoro Capital Advisors LLC
Shares: 3,725,000.00 · Class: 6.1%
- Behzad Aghazadeh
Shares: 3,725,000.00 · Class: 6.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003581
- Form type
- SCHEDULE 13G/A
- Filer
- Avoro Capital Advisors LLC
- CIK
- CIK 1633313
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership